757239-60-4 Usage
Uses
Used in Pharmaceutical Research and Synthesis:
Methyl 1-Cbz-azetidine-3-carboxylate is used as a building block for the synthesis of complex organic molecules, particularly in the development of new drugs. Its unique structure and reactivity allow for the creation of diverse chemical entities with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 1-Cbz-azetidine-3-carboxylate is employed as a valuable tool for chemists and researchers. Its carboxylic acid and Cbz protective group enable the synthesis of various compounds with potential therapeutic properties, contributing to the advancement of drug discovery and development.
Used in Drug Development:
Methyl 1-Cbz-azetidine-3-carboxylate is used as a key intermediate in the synthesis of pharmaceutical compounds, facilitating the development of new drugs with improved efficacy and safety profiles. Its unique structure allows for the exploration of novel chemical space and the optimization of drug candidates for various therapeutic areas.
Used in Organic Synthesis:
In the realm of organic synthesis, Methyl 1-Cbz-azetidine-3-carboxylate is utilized as a versatile reagent for the preparation of a wide range of organic compounds. Its carboxylic acid and Cbz protective group provide opportunities for various synthetic transformations, enabling the synthesis of complex molecules with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 757239-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,7,2,3 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 757239-60:
(8*7)+(7*5)+(6*7)+(5*2)+(4*3)+(3*9)+(2*6)+(1*0)=194
194 % 10 = 4
So 757239-60-4 is a valid CAS Registry Number.
757239-60-4Relevant academic research and scientific papers
AMINOESTER DERIVATIVES
-
Page/Page column 74; 75, (2016/11/21)
The invention relates to novel compounds which are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
THIOPHENE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
Page/Page column 27, (2011/08/06)
The subject matter of the invention is compounds corresponding to formula (I), in which: R1 and R2, together with the nitrogen atom to which they are attached, constitute a saturated heterocyclic radical containing from 4 to 7 atoms, which is preferably substituted; one of the two substituents R3 and R6 is a group Y-A-R9; Y is an oxygen atom or an —S(O)n′—, or —OSO2 group; A is an unsubstituted (C1-C4) alkylene group; R9 is an —OR19, —CH3, —NR19R20, —CONR19R20, —NR15COR19, —S(O)nR21, or —NR13SO2R21 group; —R10 is a hydrogen atom or a (C1-C4) alkyl group. The present invention also relates to the methods of preparation and the therapeutic uses of the compounds of formula (I).
